
Spike Pharmaceuticals Private Limited
Wholesale trading of pharmaceutical products and distribution of medical supplies.
Wholesale trading of pharmaceutical products and distribution of medical supplies.
Spike Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 July 2008 and has a history of 16 years and nine months. Its registered office is in Kanchipuram, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 7.32 M, as per Ministry of Corporate Affairs (MCA) records.
Kanakesathevar Balakrishnan, Vedavalli, Ramaswamy Palanivelu, and Two other members serve as directors at the Company.
Kanchipuram, Tamil Nadu, India
+91-XXXXXXXXXX
U24232TN2008PTC068584
068584
Private Limited Indian Non-Government Company
15 Jul 2008
30 Sep 2024
31 Mar 2024
Unlisted
Roc Chennai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vedavalli ![]() | Managing Director | 15-Jul-2008 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kanakesathevar Balakrishnan ![]() | Director | 15-Jul-2008 | Current |
Ramaswamy Palanivelu ![]() | Director | 10-Nov-2008 | Current |
Gangadurai Meenakshi ![]() | Director | 12-Feb-2016 | Current |
Selvaraju Nevithitha ![]() | Director | 12-Feb-2016 | Current |
Spike Pharmaceuticals Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 3.08% increase. The company also saw a slight improvement in profitability, with a 1.93% increase in profit. The company's net worth Soared by an impressive increase of 22.22%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2019, Spike Pharmaceuticals had a promoter holding of 41.56% and a public holding of 58.44%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Kanakesathevar Balakrishnan is a mutual person
Kanakesathevar Balakrishnan, Vedavalli and 2 more are mutual person
Kanakesathevar Balakrishnan and Vedavalli are mutual person
Kanakesathevar Balakrishnan and Ramaswamy Palanivelu are mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Spike Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Spike Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spike Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Spike Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Spike Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
Gangadurai Meenakshi was appointed as a Director was appointed as a Director on 12 Feb 2016 & has been associated with this company since 9 years 3 months .
Selvaraju Nevithitha was appointed as a Director was appointed as a Director on 12 Feb 2016 & has been associated with this company since 9 years 3 months .
Ramaswamy Palanivelu was appointed as a Director was appointed as a Director on 10 Nov 2008 & has been associated with this company since 16 years 6 months .
Kanakesathevar Balakrishnan was appointed as a Director was appointed as a Director on 15 Jul 2008 & has been associated with this company since 16 years 9 months .
Spike Pharmaceuticals Private Limited was incorporated on 15 Jul 2008.
The authorized share capital of Spike Pharmaceuticals Private Limited is ₹ 1.00 Cr and paid-up capital is ₹ 7.32 M.
Currently 5 directors are associated with Spike Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Spike Pharmaceuticals Private Limited is 4/19 Bharathi Salai Ponni Nagar Karambakkam, Porur India, Chennai, Tamil Nadu, 600116.
The corporate identification number (CIN) of Spike Pharmaceuticals Private Limited is U24232TN2008PTC068584 and the company number is 068584 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2020, the revenue trend for Spike Pharmaceuticals Private Limited has risen by 3.08%.
The financial reports for the fiscal year 2020 indicates that The net worth of Spike Pharmaceuticals Private Limited has experienced an upsurge of 22.22%.
The most recent Balance Sheet for Spike Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.